1. Home
  2. BGC vs ALKS Comparison

BGC vs ALKS Comparison

Compare BGC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGC Group Inc.

BGC

BGC Group Inc.

HOLD

Current Price

$8.78

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$29.36

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGC
ALKS
Founded
1945
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.8B
IPO Year
1999
1991

Fundamental Metrics

Financial Performance
Metric
BGC
ALKS
Price
$8.78
$29.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$14.50
$42.85
AVG Volume (30 Days)
2.7M
2.5M
Earning Date
11-06-2025
10-28-2025
Dividend Yield
0.91%
N/A
EPS Growth
36.46
2.44
EPS
0.33
2.02
Revenue
$2,640,884,000.00
$1,521,338,000.00
Revenue This Year
$36.34
N/A
Revenue Next Year
$11.45
$24.22
P/E Ratio
$26.63
$14.67
Revenue Growth
24.59
1.08
52 Week Low
$7.24
$25.17
52 Week High
$10.96
$36.45

Technical Indicators

Market Signals
Indicator
BGC
ALKS
Relative Strength Index (RSI) 47.99 48.29
Support Level $8.52 $28.96
Resistance Level $8.76 $30.10
Average True Range (ATR) 0.21 0.92
MACD 0.04 0.02
Stochastic Oscillator 72.79 68.21

Price Performance

Historical Comparison
BGC
ALKS

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: